Scientists who work in mycology — the study of fungi — say there is precious little money available to study Candida auris, according to an article on the STAT News website.
Candida auris is making news for its ability to resist multiple antifungal drugs and settle into hospital rooms so persistently it can take renovations to get rid of it.
The head of mycotic diseases at the Centers for Disease Control and Prevention (CDC) acknowledged his field hasn’t attracted the same kind of research dollars as other pathogens.
A high proportion of people who have been diagnosed with C. auris have died — the CDC estimates it’s between 30 percent and 60 percent.
Rethinking Strategies for Construction Success
From Touchless to Total Performance: Healthcare Restroom Design Redefined
New York State Approves $53M Construction Program at Niagara Falls Memorial Medical Center
How Health Systems Are Rethinking Facilities Amid Margin Pressure
Ground Broken on New Medical Office Building in Scottsdale, AZ